通貨 / CVAC
CVAC: CureVac N.V
5.43
USD
0.02
(0.37%)
CVACの今日の為替レートは、0.37%変化しました。日中、通貨は1あたり5.40の安値と5.44の高値で取引されました。
CureVac N.Vダイナミクスに従います。リアルタイムの相場は、市場の変化に迅速に対応するのに役立ちます。 異なる時間枠に切り替えることで、為替レートの傾向とダイナミクスを分、時間、日、週、月単位で監視できます。この情報を使用して、市場の変化を予測し、十分な情報に基づいて取引を決定してください。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
CVAC News
- Investing Deutsche Bank bearish on European pharma stocks into Q2 amid political headwinds
- Benzinga This Trade Desk Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Adaptimmune Therapeutics (NASDAQ:ADAP), ASML Holding (NASDAQ:ASML)
- Investing CureVac stock downgraded to neutral by UBS after BioNTech acquisition
- Investing CureVac shareholders approve management changes and auditor
- Seeking Alpha M&A Watch: A String Of Hot IPOs Could Spark Second-Half Dealmaking
- Benzinga This Sherwin-Williams Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Friday - CureVac (NASDAQ:CVAC), Dayforce (NYSE:DAY)
- Investing Jefferies cuts CureVac stock rating to hold on BioNTech acquisition
- Seeking Alpha BioNTech's Acquisition Of CureVac Brings Complementary Method To Target Cancer (BNTX)
- Investing Oracle, GameStop Lead Market Cap Stock Movers on Thursday
- TipRanks Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories - TipRanks.com
- Benzinga Nasdaq Moves Higher; Oracle Shares Jump After Upbeat Q4 Results - CureVac (NASDAQ:CVAC), Helius Medical Tech (NASDAQ:HSDT)
- TipRanks M&A News: BioNTech (BNTX) Acquires CureVac in $1.25 Billion Deal - TipRanks.com
- Benzinga BioNTech Expands mRNA Cancer Portfolio With CureVac $1.25 Billion All-Stock Deal - CureVac (NASDAQ:CVAC), Novavax (NASDAQ:NVAX)
- Benzinga CureVac, TELUS International, Oracle And Other Big Stocks Moving Higher On Thursday - CureVac (NASDAQ:CVAC), DeFi Development (NASDAQ:DFDV)
- Investing Oracle and GameStop Headline Market Cap Stock Movers on Thursday
- Investing BioNTech takes over CureVac in $1.25 billion all-stock deal among COVID rivals
- Investing Oracle and CureVac rise premarket; Boeing and GameStop fall
- Investing CureVac stock soars about 30% after BioNTech agrees to acquire co
- MarketWatch Gundlach says gold is no longer for lunatics as the bond king says wait to buy the 30-year
- Investing BioNTech to acquire CureVac in $1.25 billion all-stock deal
- Benzinga Trump Administration Terminates $590 Million Moderna Bird Flu Vaccine Deal, Dismantling Biden-Era Pandemic Preparedness Effort - CureVac (NASDAQ:CVAC), Moderna (NASDAQ:MRNA)
- Investing CureVac stock maintains $10 target from JMP on GBM vaccine outlook
- Benzinga CureVac (CVAC) Stock Rises After Q1 Update, Oncology Pipeline Gains Traction - CureVac (NASDAQ:CVAC)
- Investing CureVac Announces Financial Results for the First Quarter of 2025 and Provides Business Updates
1日のレンジ
5.40
5.44
1年のレンジ
2.37
5.72
- 以前の終値
- 5.41
- 始値
- 5.41
- 買値
- 5.43
- 買値
- 5.73
- 安値
- 5.40
- 高値
- 5.44
- 出来高
- 308
- 1日の変化
- 0.37%
- 1ヶ月の変化
- 1.12%
- 6ヶ月の変化
- 49.18%
- 1年の変化
- 45.19%
30 7月, 水曜日
12:15
USD
- 実際
- 104 K
- 期待
- 57 K
- 前
- -33 K
12:30
USD
- 実際
- 3.0%
- 期待
- 0.4%
- 前
- -0.5%
12:30
USD
- 実際
- 2.0%
- 期待
- 3.6%
- 前
- 3.8%
12:30
USD
- 実際
- 2.5%
- 期待
- 3.3%
- 前
- 3.5%
12:30
USD
- 実際
- 2.1%
- 期待
- 3.1%
- 前
- 3.7%
12:30
USD
- 実際
- 1.4%
- 期待
- 0.8%
- 前
- 0.5%
12:30
USD
- 実際
- 6.3%
- 期待
- -1.5%
- 前
- -3.1%
14:00
USD
- 実際
- -0.8%
- 期待
- 1.6%
- 前
- 1.8%
14:00
USD
- 実際
- -2.8%
- 期待
- 9.6%
- 前
- 1.1%
14:00
USD
- 実際
- 72.0
- 期待
- 前
- 72.6
14:30
USD
- 実際
- 7.698 M
- 期待
- 0.914 M
- 前
- -3.169 M
14:30
USD
- 実際
- 0.690 M
- 期待
- 0.114 M
- 前
- 0.455 M
14:30
USD
- 実際
- 1.317 M
- 期待
- 0.738 M
- 前
- -0.740 M
14:30
USD
- 実際
- 0.130 M
- 期待
- -0.004 M
- 前
- 0.095 M
14:30
USD
- 実際
- 3.635 M
- 期待
- -0.111 M
- 前
- 2.931 M
14:30
USD
- 実際
- 0.676 M
- 期待
- 0.915 M
- 前
- 0.282 M
14:30
USD
- 実際
- 0.739 M
- 期待
- 0.608 M
- 前
- 0.003 M
14:30
USD
- 実際
- -2.724 M
- 期待
- 0.879 M
- 前
- -1.738 M
14:30
USD
- 実際
- -0.025 M
- 期待
- 前
- 0.087 M
14:30
USD
- 実際
- -0.1%
- 期待
- 前
- 1.6%
18:00
USD
- 実際
- 期待
- 前
18:00
USD
- 実際
- 4.50%
- 期待
- 前
- 4.50%
18:30
USD
- 実際
- 期待
- 前